NPNicole R. Pouppirt

Nicole R. Pouppirt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Nicole R. Pouppirt has a total of 72 co-authors. Here are the top co-authors by number of shared publications:

  • Akira Nishisaki

    Department of Anesthesiology, Critical Care Medicine, and Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA

    2 shared publications
  • Elizabeth E. Foglia

    Department of Pediatrics, Division of Neonatology, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA

    2 shared publications
  • Natalie Napolitano

    Department of Biostatistics, Epidemiology and Informatics in the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA

    2 shared publications
  • Ahmed Moussa

    1 shared publication
  • Alicia J. Spittle

    Murdoch Children’s Research Institute, Melbourne, Victoria, Australia

    1 shared publication
  • Ann K. Barlow

    Affiliation Shirley Ryan AbilityLab, Chicago, Illinois, United States of America

    1 shared publication

Latest Publications

  • Association of atropine use during neonatal intubation with cardiac arrest, severe bradycardia, and other adverse events: a report from NEAR4NEOS

    by Taylor Sawyer, Michael Narvey, Michelle D. Tyler, Ayman Abou Mehrem, Sabine Iben, Cassandra DeMartino, David Tingay, Kate Hodgson, Jae Kim, Heidi Herrick, et al.

  • Open Access

    Protocol for a randomized controlled trial to evaluate a year-long (NICU-to-home) evidence-based, high dose physical therapy intervention in infants at risk of neuromotor delay

    by Weiyang Deng, Sofia Anastasopoulos, Raye-Ann Deregnier, Nicole Pouppirt, Ann K. Barlow, Cheryl Patrick, Megan K. O’brien, Sarah Babula, Theresa Sukal-Moulton, Colleen Peyton, et al.

    Developmental disabilities and neuromotor delay adversely affect long-term neuromuscular function and quality of life. Current evidence suggests that early therapeutic intervention reduces the severity of motor delay by harnessing neuroplastic potential during infancy. To date, most early therapeutic intervention trials are of limited duration and do not begin soon after birth and thus do not take full advantage of early neuroplasticity. The Corbett Ryan–Northwestern–Shirley Ryan AbilityLab–Lurie Children’s Infant Early Detection, Intervention and Prevention Project (Project Corbett Ryan) is a multi-site longitudinal randomized controlled trial to evaluate the efficacy of an evidence-based physical therapy intervention initiated in the neonatal intensive care unit (NICU) and continuing to 12 months of age (corrected when applicable). The study integrates five key principles: active learning, environmental enrichment, caregiver engagement, a strengths-based approach, and high dosage (ClinicalTrials.gov identifier NCT05568264). We will recruit 192 infants at risk for neuromotor delay who were admitted to the NICU. Infants will be randomized to either a standard-of-care group or an intervention group; infants in both groups will have access to standard-of-care services. The intervention is initiated in the NICU and continues in the infant’s home until 12 months of age. Participants will receive twice-weekly physical therapy sessions and caregiver-guided daily activities, assigned by the therapist, targeting collaboratively identified goals. We will use various standardized clinical assessments (General Movement Assessment; Bayley Scales of Infant and Toddler Development, 4th Edition (Bayley-4); Test of Infant Motor Performance; Pediatric Quality of Life Inventory Family Impact Module; Alberta Infant Motor Scale; Neurological, Sensory, Motor, Developmental Assessment; Hammersmith Infant Neurological Examination) as well as novel technology-based tools (wearable sensors, video-based pose estimation) to evaluate neuromotor status and development throughout the course of the study. The primary outcome is the Bayley-4 motor score at 12 months; we will compare scores in infants receiving the intervention vs. standard-of-care therapy.


  • Impact of prenatal exposure characterization on early risk detection: Methodologic insights for the HEALthy Brain and Child Development (HBCD) study

    by Suena H. Massey, Norrina B. Allen, Lindsay R. Pool, Emily S. Miller, Nicole R. Pouppirt, Deanna M. Barch, Joan Luby, Susan B. Perlman, Cynthia E. Rogers, Chris D. Smyser, et al.


  • The General Movements Assessment in Neonates With Hypoxic Ischemic Encephalopathy

    by Nicole R. Pouppirt, Valerie Martin, Linda Pagnotto-Hammitt, Alicia J. Spittle, John Flibotte, Sara B. DeMauro

    Background: Clinical measures after birth and studies such as electroencephalogram (EEG) and brain imaging do not fully predict neurodevelopmental outcomes of infants with hypoxic-ischemic encephalopathy. Early detection of adverse neurologic outcomes, and cerebral palsy in particular, in high-risk infants is essential for ensuring timely management. The General Movements Assessment is a tool that can be used in the early detection of cerebral palsy in infants with brain injury. The majority of studies on the General Movements Assessment in the late preterm and term population were performed prior to the introduction of therapeutic hypothermia. Aims: To apply the General Movements Assessment in late preterm and term infants with hypoxic-ischemic encephalopathy (including those who received therapeutic hypothermia), to determine if clinical markers of hypoxic-ischemic encephalopathy predict abnormal General Movements Assessment findings, and to evaluate interrater reliability of the General Movements Assessment in this population. Study design: Pilot prospective cohort study Subjects: We assessed 29 late preterm and full-term infants with mild, moderate, and severe hypoxic-ischemic encephalopathy in Philadelphia, PA. Results: Most infants’ general movements normalized by the fidgety age. Only infants with moderate or severe hypoxic-ischemic encephalopathy had abnormal general movements in both the writhing and the fidgety ages (n = 6). Seizure at any point during the initial hospitalization was the clinical sign most predictive of abnormal general movements in the fidgety age (sensitivity 100%, specificity 55%, positive predictive value 40%, negative predictive value 100%). Interrater reliability was greatest during the fidgety age (κ = 0.67). Conclusions: Seizures were the clinical predictor most closely associated with abnormal findings on the General Movements Assessment. However, clinical markers of hypoxic-ischemic encephalopathy are not fully predictive of abnormal General Movements Assessment findings. Larger future studies are needed to evaluate the associations between the General Movements Assessment and childhood neurologic outcomes in patients with hypoxic-ischemic encephalopathy who received therapeutic hypothermia.


  • Association Between Video Laryngoscopy and Adverse Tracheal Intubation-Associated Events in the Neonatal Intensive Care Unit

    by Nicole R. Pouppirt, Rula Nassar, Natalie Napolitano, Ursula Nawab, Akira Nishisaki, Vinay Nadkarni, Anne Ades, Elizabeth E. Foglia